BotCast #44 – Ahh H1N1 Virus waiting

BotCast #44 USS Tropicana se joint à Botrax & TestDummy pour parler de la fausse pandémie du AH1N1 et de la vaccination. USS Tropicana nous explique comment il s’est défait de ses contraventions données par la STM.
(22 février 2010) 2h57m16s

DOWNLOAD: BotCast-0044-Surround.mp3 STREAM: BotCast-0044-Surround.m3u

Break: Frank Klepacki, “Virus”,
Surround OutTro: Jugi, “Waiting” ,
Remerciements:, et Pandem Inc.






Do Flu Shots Work Ask A Vaccine Manufacturer (cache)

What’s In A Flu Shot (cache)

Mercury is good for you! – US Mainstream Media Report (cache)

Is HPV Vaccine Safe? (cache)


How Mercury Causes Brain Neuron Damage – Uni. of Calgary (cache)

Medical Doctor Retracts H1N1 Vaccine Advice After Reading Insert! (cache)

Dre Laberge à Salut Bonjour! explique les symptômes du H1N1 et quoi faire en cas de contagion. (cache)




The federal government won’t say if Canadians who suffer harmful side effects from the new swine flu shot can take the vaccine maker to court.
The Public Health Agency of Canada will not reveal whether drug companies are shielded from H1N1 flu vaccine lawsuits in this country like they are in the United States. (cache)


The silence about vaccine deaths in media is due to the confidential contracts with the vaccine manufacturers.

If you can read French, you will discover at that the maker of PandemRix, that is used in Sweden, passed a secret contract, the same in every European country, which specified a “Green List” of what the government MAY communicate (hardly anything!) and the “Red List” of what may absolutely NOT be made public, like intermediary results of the side effects that appear in the studies of the controversial squalene (and thiomersal) adjuvantated PandemRix until they have been sanitized by Glaxo Smith Kline researchers, and published by GSK themselves.

Doctors Bribed To Push Swine Flu Vaccine On Reluctant Public

Doctors Bribed To Push Swine Flu Vaccine On Reluctant Public Health authorities offer extra bonuses for each shot in an attempt to counter mass resistance to (cache)

Conflicts of interest? Dr. Mehmet Oz owns 150,000 option shares in vaccine technology company
Dr. Mehmet Oz is a huge promoter of vaccines. He’s been on television reinforcing fear about H1N1 swine flu and telling everyone to get vaccinated. But what he didn’t tell his viewing audience is that he holds 150,000 option shares in a vaccine company that could earn him millions of dollars in profits as the stock price rises. It is in Dr. Oz’s own financial interest, in other words, to hype up vaccines and get more people taking them so that his own financial investments rise in value. (cache)

H1N1 a ‘dud’ pandemic, Ont. health official says
The huge investments governments made in swine flu pandemic planning might not have been justified, an Ontario health official said Thursday.
“It’s really not causing — and is not going to cause and nowhere has caused — significant levels of illness or death,” said Dr. Richard Schabas, Ontario’s former chief medical officer of health.
“But governments moved ahead regardless. They ramped up their response, spent a huge amount of money on vaccines and other things. I’m not sure the $1.5 billion includes the cost of new ventilators, the cost of Tamiflu stockpiles … the huge investment that’s been put into planning for what has ultimately turned out to be, from a pandemic perspective, a dud.” (cache)

Barack Obama has shares in Baxter
The President of the United States, Barack Obama has shares in Baxter, the company many say is responsible for the h1n1 swine flu pandemic. Back 2005 Barack Obama bought $50,000 worth of stock in two companies.
Right after he bought the shares also in 2005 Barack Obama (still a senator at that time) introduced the first comprehensive bill to address the threat of avian influenza pandemic. AVIAN Act (S. 969)
Then it makes it even more interesting that over $60 million dollars was awarded for a vaccine against the bird flu (2007) that at the time did not mutate till afterwards.
The guy sure knows his planning, I guess that is change you can believe in. From investor to President. (cache)

Aspirin kills 400% more people than H1N1 swine flu
The CDC now reports that nearly 4,000 Americans have been killed by H1N1 swine flu. This number is supposed to sound big and scary, motivating millions of people to go out and pay good money to be injected with untested, unproven H1N1 vaccines. But let’s put the number in perspective: Did you know that more than four times as many people are killed each year by common NSAID painkillers like aspirin? (cache)

Batch of H1N1 vaccine recalled for severe reactions
Batch of H1N1 vaccine recalled for severe reactions
November 20, 2009

Comments on this story Comments(39)

Joanna Smith

Related Where to get vaccinated
Your H1N1 questions
Complete H1N1 coverage
Kids with asthma at risk
Ontario swine flu map (Nov…
More on SwineFlu Virus experiment reminds… WHO to determine if H1N1… H1N1 vaccine may be part of… WHO dismisses claims H1N1… Extra H1N1 shots heading…

Most Read Youth in a bottle getting…
Tanning addiction can be…
Beware the ‘cure’ for…
Fears grip Windsor in wake…
Comic Rick Green talks…

OTTAWA – A batch of swine flu vaccine is being pulled back for investigation after it appeared to cause higher rates of severe allergic reactions than other lots.

GlaxoSmithKline Inc., which is producing the Canadian order of H1N1 influenza vaccine at its plant in Ste-Foy, Que., said it asked provincial and territorial health authorities Wednesday to stop using doses from a specific lot shipment distributed late last month.

“(GlaxoSmithKline) is taking this cautionary action because (the Public Health Agency of Canada) has received a higher than expected number of reports of anaphylaxis in this lot number compared to other lots,” company spokeswoman Megan Spoore said in a statement. “On an ongoing basis (GlaxoSmithKline) is working with Health Canada to ensure that each vaccine lot released to the provinces and territories consistently meets quality and safety standards.”

The batch under investigation by the federal government and GlaxoSmithKline bears the lot number A80CA007A brand name Arepanrix, which is the version that contains adjuvant, a chemical additive that stretches supply and boosts immunity.

Manitoba health officials say they have noticed severe allergic reactions from the batch in question at a rate of one in 20,000, which is much higher than the normal rate of one in 100,000.

A spokesman for the Ontario health ministry said 1,500 doses of this vaccine were distributed to Ontario and sent to two public health units: Perth Health Unit and Renfrew Health Unit.

“This vaccine was not administered to any persons and is being withheld until the analysis is complete,” David Jensen wrote in an email Friday.

Meanwhile, federal Health Minister Leona Aglukkaq announced during Question Period in the House of Commons Friday that provinces and territories can expect to receive 4.8 million doses of the H1N1 vaccine by the end of next week.

Ontario is expected to receive 1.86 million of those doses.

That would bring the total number of doses shipped across the country by Nov. 29 to 15.3 million.

The Public Health Agency of Canada has released its first weekly surveillance report for the H1N1 influenza pandemic vaccine since the immunization campaign began three weeks ago and the data show that from Oct. 21 to Nov. 7 – when 6.6 million doses had been shipped across the country – only 36 people experienced serious adverse events including life-threatening allergic reactions called anaphylaxis and febrile convulsions brought on by high fever.

That number includes one death from anaphylaxis that is currently being investigated and which a spokeswoman for the Quebec health ministry has confirmed was an octogenarian who died in that province two weeks ago.

“With any vaccination campaign, we expect to see some cases of serious adverse events,” Dr. David Butler-Jones, Canada’s chief public health officer, said at a news conference Tuesday.

“They are very rare, but they are part of all mass vaccination campaigns and we expect to see a small number of them.”

The rate of serious adverse events is so far 0.54 per 100,000 doses distributed, which Butler-Jones noted is less than what is generally expected for the seasonal flu vaccine.

An additional 598 milder adverse reactions were reported during the same time period. The majority of those involved nausea, dizziness, headache, fever, vomiting and swelling or soreness at the site of the injection.

There were also several reports of allergic reactions with a range of symptoms, from hives and skin rashes to tingling lips or tongue and difficulty breathing. Most of those occurred within minutes after people received their shot in the arm and staff at the flu clinics treated them right away.–batch-of-h1n1-vaccine-recalled-for-severe-reactions

Severe reactions to swine flu vaccine in Canada: WHO
Agence France-PresseNovember 24, 2009 5:05 AM
GENEVA — An unusual number of severe allergic reactions to swine flu vaccinations have been recorded in Canada, where a batch of the vaccine from GlaxoSmithKline has been recalled, the WHO said on Tuesday.

“An unusual number of severe allergies to the vaccine have been detected in Canada,” World Health Organization spokesman Thomas Abraham told AFP.
“The Canadian authorities are conducting the appropriate investigations on the vaccines” and “recalled a batch of vaccine from GSK.”
“We need to understand what happened in Canada,” he added.
Mr. Abraham said, however, that the WHO had not changed its recommendations regarding swine flu vaccines.
Last week, the WHO said checks on many of the 30 deaths recorded following mass pandemic flu vaccinations had so far ruled out a direct link to the vaccines.
The fatalities made up a minute fraction of at least 65 million doses of swine flu vaccines which have been administered, said the WHO, citing data from 16 countries.
For every 10,000 doses of vaccines administered, only one report of adverse effect had been logged.
Of every 100 reports of adverse effects, five are serious cases such as death, according to the WHO. (cache)

Tamiflu anti-viral drug revealed as complete hoax; Roche studies based on scientific fraud
When it comes to selling chemicals that claim to treat H1N1 swine flu, the pharmaceutical industry’s options are limited to two: Vaccines and anti-virals. The most popular anti-viral, by far, is Tamiflu, a drug that’s actually derived from a Traditional Chinese Medicine herb called star anise.
But Tamiflu is no herb. It’s a potentially fatal concentration of isolated chemical components that have essentially been bio-pirated from Chinese medicine. And when you isolate and concentrate specific chemicals in these herbs, you lose the value (and safety) of full-spectrum herbal medicine. (cache)

Hundreds fall ill after having swine flu jab
Swine flu vaccine has caused adverse reactions in 619 people to date, varying from seizures and anaphylactic shock to fainting and vomiting. (cache)

Advisers on Vaccines Often Have Conflicts, Report Says
WASHINGTON — A new report finds that the Centers for Disease Control and Prevention did a poor job of screening medical experts for financial conflicts when it hired them to advise the agency on vaccine safety, officials said Thursday.

Most of the experts who served on advisory panels in 2007 to evaluate vaccines for flu and cervical cancer had potential conflicts that were never resolved, the report said. Some were legally barred from considering the issues but did so anyway.

In the report, expected to be released Friday, Daniel R. Levinson, the inspector general of the Department of Health and Human Services, found that the centers failed nearly every time to ensure that the experts adequately filled out forms confirming they were not being paid by companies with an interest in their decisions.

The report found that 64 percent of the advisers had potential conflicts of interest that were never identified or were left unresolved by the centers. Thirteen percent failed to have an appropriate conflicts form on file at the agency at all, which should have barred their participation in the meetings entirely, Mr. Levinson found. And 3 percent voted on matters that ethics officers had already barred them from considering.

The inspector general recommended that the centers do a far better job of screening. In a reply, the agency’s new director, Dr. Thomas R. Frieden, agreed.

“Since the period covered in this review, C.D.C. has strengthened the financial disclosures and conflict-of-interest process by instituting improved business processes and realigning responsibilities and oversight,” Dr. Frieden wrote.

As numerous medicines have been pulled from the market in recent years, worries have grown that experts may be recommending medical products — even ones they know to be unsafe — in part because manufacturers are paying them.

As a result, government agencies, medical societies and medical journals have become increasingly insistent that experts disclose potential conflicts. And while the experts invariably insist that they have done so, government audits routinely find large gaps between these disclosures and the experts’ actual income from consulting.

Congress tightened the rules on outside consulting after similar conflicts were found among members of advisory panels to the Food and Drug Administration. But little attention has been paid to the potential conflicts of advisers to the C.D.C., even though that agency’s committees have significant influence over what vaccines are sold in the United States, what tests are performed to detect cancer and how coal miners are protected.

Most of the advisers identified by Mr. Levinson had either a job or a grant from a company or other entity whose interests were affected by the committees’ discussions, and a considerable number also owned stock in such companies, the report said.

Representative Rosa DeLauro, a Connecticut Democrat who said she had long been a supporter of the C.D.C., said: “That is why I am so concerned about this report issued by the inspector general exposing serious ethics violations within the C.D.C. All members of the federal advisory committees, whose recommendations direct federal policy, should be without conflict of interest.”

Former head of CDC lands lucrative job as president of Merck vaccine division
You’ve heard it before, how the pharmaceutical industry has a giant “revolving door” through which corporations and government agencies frequently exchange key employees. That reality was driven home in a huge way today when news broke that Dr. Julie Gerberding, who headed the Center for Disease Control (CDC) from 2002 through 2009, landed a top job with Merck, one of the largest drug companies in the world. Her job there? She’s the new president of the vaccine division.
How convenient. That means the former head of the CDC was very likely cultivating a relationship with Merck all these years, and now comes the big payoff: Heading up a $5 billion division that sells cervical cancer vaccines (like Gardasil), chickenpox vaccines and of course H1N1 swine flu vaccines, too. (cache)

France sells off surplus swine flu vaccine
France is selling off millions of surplus swine flu vaccine doses to other countries, officials say.
They say the move was decided after health authorities found they had more than enough to deal with the outbreak.

The government bought 94 million swine flu vaccine doses – more than one for every French person – and started vaccinating in October.
Only about five million people are recorded as having been vaccinated in France so far, AFP reports. (cache)

Swine flu taskforce’s links to vaccine giant: More than half the experts fighting the ‘pandemic’ have ties to drug firms
More than half the scientists on the swine flu taskforce advising the Government have ties to drug companies.
Eleven of the 20 members of the Scientific Advisory Group for Emergencies (SAGE) have done work for the pharmaceutical industry or are linked to it through their universities.
Many have declared interests in GlaxoSmithKline, the vaccine maker expected to be the biggest beneficiary of the pandemic.
The disclosure of the register of interests comes just days after a health expert branded the swine flu outbreak a ‘false pandemic’ driven by the drug companies which stood to profit. (cache)

Thousands of Americans died from H1N1 even after receiving vaccine shots
The CDC is intentionally not tracking how many of the dead were previously vaccinated. They want you (and mainstream media journalists) to mistakenly believe that ZERO deaths occurred in those who were vaccinated. But this is blatantly false. Being vaccinated against H1N1 swine flu offers absolutely no reduction in mortality from swine flu infections.
And that means roughly 20% of the 11,160 Americans who died from the swine flu were probably already vaccinated against swine flu. That comes to around 2,200 deaths in people who were vaccinated! (cache)

Mumps outbreak spreads among people who got vaccinated against mumps
To hear the vaccine pushers say it, all the recent outbreaks of mumps and measles are caused by too few people seeking out vaccinations. It’s all those “non-vaccinated people” who are a danger to society, they say, because they can spread disease.
Reality tells a different story, however: It is the vaccinated people who are causing these outbreaks and spreading disease!
Just this week, an outbreak of mumps among more than 1,000 people in New Jersey and New York has raised alarm among infectious disease authorities. The outbreak itself is not unusual, though. What’s unusual is that the health authorities slipped up and admitted that most of the people infected with mumps had already been vaccinated against mumps. (cache)

One comment

  1. Pingback: Feu de l’Esprit #2 – Ebola louche – Feu de l'Esprit

Leave a Reply

Your email address will not be published. Required fields are marked *